BeStock  
Stocks › Biotechnology › CGEM

Cullinan Therapeutics CGEM

US equityMarket cap rank #3236Biotechnology
$15.63 −$0.62 (-3.82%)
Pre-market · Oct 8, 8:00 am ET · After hours $15.63 0.00%
Open$15.95
Prev close$16.25
Day range$15.47 – $16.46
Volume808.2K
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-13.0%BearishTrading below the 20-day average of $17.96
Price vs 50-day average-19.2%BearishTrading below the 50-day average of $19.35
Price vs 200-day average+1.2%BullishTrading above the 200-day average of $15.44
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)35.9BearishMomentum leans negative
MACD (12,26,9)-1.38BearishMACD line is below its signal line
Bollinger band position29%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$17.96-13.0%
50-day SMA$19.35-19.2%
200-day SMA$15.44+1.2%

Recent price levels

LevelPrice
20-day high$21.88
20-day low$14.20
60-day high$23.19
60-day low$14.20
Upper Bollinger band$23.64
Lower Bollinger band$12.29

The 50-day average is currently 25.3% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility85.4%
Average true range8.56% of price
Max drawdown (1y)-36.7%
Volume (10d vs 90d)1.38x

Discussion

No comments yet — be the first to weigh in on CGEM.

Leave a comment

Scroll to Top